# INHIBRX BIOSCIENCES INC (INBX)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/INBX/

- Reporting holders: 5
- Reported value: $719.9K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Persium Advisors, LLC](https://holderbook.com/funds/2033683-persium-advisors-llc/) | $487.9K | 4,875 | 0.3% | 2 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $186.9K | 1,868 | 0.0% | 10 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $27.9K | 279 | 0.0% | 10 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $16.8K | 168 | 0.0% | 7 |
| [CoreCap Advisors, LLC](https://holderbook.com/funds/1902501-corecap-advisors-llc/) | $300 | 3 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 5 | $719.9K |
| Q2 2026 | 168 | $1.5B |
| Q1 2026 | 138 | $880.8M |
| Q4 2025 | 142 | $1.1B |
| Q3 2025 | 104 | $356.5M |
| Q2 2025 | 89 | $148.9M |
| Q1 2025 | 93 | $152.2M |
| Q4 2024 | 103 | $174.1M |
| Q3 2024 | 98 | $145.6M |
| Q2 2024 | 89 | $142.5M |
| Q1 2024 | 127 | $1.4B |
| Q4 2023 | 127 | $1.6B |